Skip to main content

Get the latest public health information from CDC

Clinical Info HIV.gov logo
In affiliation with HIV.gov
Main navigation
  • Home
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • English
  • Español (Spanish)

Language:

  • English
  • Español

clinical info.hiv.gov

Offering Information on HIV/AIDS Treatment, Prevention, and Research

Guidance for Covid-19 and People with HIV is now available.

See Guidance 

Clinical Guidelines

Federally approved medical practice guidelines for HIV/AIDS.
Guidelines 

Drug Database

Information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs. Drugs 

Glossary

Medical dictionary of HIV-related terms.
Glossary 

Resources

HIV-related resources from the National Institutes of Health.
Resources 

Mobile Application

Mobile App Information 
The Clinical Info mobile application gives access to federally approved treatment and research information for HIV and AIDS, optimized for mobile devices free of charge.

Download the beta version of the Clinical Info App for your iOS or Android device.




 

Clinical Info mobile app icon

Download ClinicalInfo Guidelines app on the AppStore
Download ClinicalInfo Guidelines app on GooglePlay

Characteristics of Protease Inhibitors

  • Read more about Characteristics of Protease Inhibitors

Characteristics of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

  • Read more about Characteristics of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

  • Read more about Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Nucleoside Reverse Transcriptase Inhibitor-Based, Fixed-Dose Combination Tablets for Use as Part of an Antiretroviral Regimen

  • Read more about Nucleoside Reverse Transcriptase Inhibitor-Based, Fixed-Dose Combination Tablets for Use as Part of an Antiretroviral Regimen

Coformulated and Copackaged Antiretroviral Regimens

  • Read more about Coformulated and Copackaged Antiretroviral Regimens

General Terms

  • Read more about General Terms

Drug Name Abbreviations

  • Read more about Drug Name Abbreviations

Interactions between Integrase Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors or Protease Inhibitors

  • Read more about Interactions between Integrase Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors or Protease Inhibitors

Interactions between Non-Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors

  • Read more about Interactions between Non-Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors

Drug Interactions between CCR5 Antagonist and Other Drugs

  • Read more about Drug Interactions between CCR5 Antagonist and Other Drugs

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Current page 13
  • Page 14
  • Page 15
  • Page 16
  • Next page Next ›
  • Last page Last »

Connect with us

Facebook
Twitter
Instagram
Subscribe

Footer menu

  • Home
  • About
  • Mobile Application
  • News
  • Contact Us
  • Privacy Policy
  • Sponsors
  • Nondiscrimination Notice
  • Disclaimers
  • Accessibility
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.